Identification of novel, selective and potent Chk2 inhibitors.

Bioorg Med Chem Lett

Drug Discovery, Valeant Pharmaceutical Research and Development 3300 Hyland Avenue, Costa Mesa, CA 92626, USA.

Published: January 2007

A series of isothiazole carboxamidine compounds were synthesized and discovered as novel and selective inhibitors for Chk2. They are not active against the related Chk1 kinase. The structure-activity relationship studies were performed on the scaffold, and enzymatic kinetic analysis showed they are simple ATP competitive inhibitors with K(i) values as low as 11 nM for Chk2. Computer modeling studies were employed to comprehend the mechanism of action and SAR of these compounds.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.09.067DOI Listing

Publication Analysis

Top Keywords

novel selective
8
identification novel
4
selective potent
4
potent chk2
4
chk2 inhibitors
4
inhibitors series
4
series isothiazole
4
isothiazole carboxamidine
4
carboxamidine compounds
4
compounds synthesized
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!